Objective. To investigate the development and T cell receptor (TCR) usage of CD8+, CD57+ T cells in rheumatoid arthritis (RA) patients.Methods. Three-color flow cytometry using monoclonal antibodies (MAb) to CD8, CD57 and different TCR V, gene products.Results. The proportion of CD8+ T cells expressing CD57 (CD57/CDS) was significantly higher in RA patients compared with age-matched controls. Expanded TCR V, populations were more frequent, and were found in both RA patient-derived CDShigh+ (CD57+) and CDS+, CD57-populations. TCR V,5+ and TCR V,13+ expansions were present at high frequency (5 of 26 and 7 of 26, respectively). TCR V, expansions in CDShigh+ (CD57+) lymphocytes from RA patients were significantly larger than those in age-matched controls (expansion index 2.38 f 0.28, n = 41 and 1.63 f 0.09, n = 32, respectively), and were stable over time.Conclusion. RA leads to an increase in the frequency of expanded CD8+ T cell subsets expressing selected TCR, due to expansion of TCR V,+ populaPreliminary data from this study were presented as a poster at the 9th International Immunology Congress, San Francisco, California, 1995.